UNSPSC 51302336: Isoconazole nitrate

This classification denotes an antifungal agent with the molecular formula C18H14Cl4N2O.HNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5AS8P3N30X, chemically known as 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)-, mononitrate but more generally known as isoconazole nitrate, which bears US NIH Compound Identifier 159968. European Medicines Agency schedules Isoconazole nitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02786MIG.

UNSPSC 51302336 Isoconazole nitrate is a Commodity code covering a topical antifungal pharmaceutical ingredient that state and local governments procure as a component of broader medical supply inventories. Recent solicitation activity shows the code is tagged in requests for comprehensive first-aid and medical supply bundles, though the actual procurement spans multiple product categories including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first-aid kits, and emergency blankets rather than isoconazole-specific acquisitions alone. State and local purchasing offices, fire rescue departments, and public safety agencies use this code when sourcing medical consumables for emergency response and occupational health programs. The City of Tampa Fire Rescue Department is a documented buyer in this space, issuing procurement notices that bundle individual pharmaceutical and supply line items under single aggregate solicitations.

Geographic activity in isoconazole nitrate procurement centers on Florida, where the City of Tampa's ITB 25P00157 for Medical Aid Supplies posted in April 2026 with a bid opening date of April 9, 2025 and a total departmental budget of $100,000. The solicitation targets a 32-item medical supply list with estimated annual quantities ranging from 1 to 2,700 units per item and anticipates an initial one-year award with two potential one-year renewals. Tampa's procurement includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) receiving a 5% bid discount capped at $10,000 and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) receiving a 5% discount capped at $20,000. The notice requires bidders to submit electronic proposals through the OpenGov eProcurement Portal and to provide Letters of Intent on Form MBD-40 within ten work days of bid opening, with all medications subject to a minimum nine-month expiration date from date of acceptance.